Assessment of usefulness of AFP as a tumor marker in cases of HCC
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 3, Pages 1835-1839
AbstractBackground:Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related
death worldwide. The present study was conducted to assess usefulness of AFP as a tumor
marker in cases of HCC.
Materials & Methods:72 hepatocellular carcinoma patients of both genders were enrolled. 5
ml of venous blood was taken and level of AFP was measured.
Results: Out of 72, males were 42 and females were 30. There were 30 HBV, 12 HCV, 10
HBV and HCV positive, 7 HBV and HCV negative, 5 AFB1 positive and 8 HBV and AFB1
positive. AFP positivity was seen in 18, 3, 8, 2, 3 and 4 respectively. The mean AFP titre
level (ng/ml) was 504.2, 482.6, 572.4, 461.2, 476.2 and 224.7 respectively. The difference
was significant (P< 0.05).
- Article View: 171
- PDF Download: 156